Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Change in Cash (2024 - 2026)

Carlsmed posted quarterly Change in Cash of -$12.8 million for Q1 2026, down 486.36% year-on-year from $3.3 million in Q1 2025, and up 56.81% on a QoQ basis from -$29.6 million in Q4 2025.

Carlsmed (CARL) has 3 years of Change in Cash data on file, last reported at -$12.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash fell 486.36% year-over-year to -$12.8 million; the trailing twelve-month figure through Mar 2026 stood at $29.6 million (changed N/A YoY), and the FY2025 full-year result was $45.7 million, up 39.01% from the prior year.
  • Change in Cash for Q1 2026 stood at -$12.8 million, up from -$29.6 million in the prior quarter.
  • Across five years, Change in Cash topped out at $81.9 million in Q3 2025 and bottomed at -$29.6 million in Q4 2025.
  • The 3-year median for Change in Cash is -$4.3 million (2024), against an average of $5.0 million.
  • Peak annual rise in Change in Cash reached 1201.67% in 2025, while the deepest fall reached 585.52% in 2025.
  • A 3-year view of Change in Cash shows it stood at -$4.3 million in 2024, then slumped by 585.52% to -$29.6 million in 2025, then surged by 56.81% to -$12.8 million in 2026.
  • The last three Change in Cash figures came in at -$12.8 million (Q1 2026), -$29.6 million (Q4 2025), and $81.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -238.90 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 800.32 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -53.56 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -21.68 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 154.34 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn -14.11 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 16.32 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -60.16 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 39.93 Mn
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn -12.78 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.78 Mn
Dec 31, 2025 -29.58 Mn
Sep 30, 2025 81.90 Mn
Jun 30, 2025 -9.96 Mn
Mar 31, 2025 3.31 Mn
Dec 31, 2024 -4.32 Mn
Sep 30, 2024 6.29 Mn